Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine in infraspinatus-teres minor interfascial block for arthroscopic shoulder surgery
ChiCTR2500105850Phase 4Not yet recruiting
- Sponsor
- Dafeng People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in Rotator cuff deficiency (RCD) and postoperative pain (3 arms), sponsored by Dafeng People's Hospital. Primary endpoint: Numeric graded score of pain (NRS). Planned start Jul 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
Rotator cuff deficiency (RCD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2500105850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105850.